BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 26, 2020
View Archived Issues
Universal flu vaccine more challenging than anticipated
Read More
Patient genetic variants linked to wound microbiomes
Read More
New way to target drugs, independently of drug target
Read More
TG-6010, a new vaccinia virus product, demonstrates potent antitumor effects
Read More
IND clearance for phase II study of HST-5040 for methylmalonic acidemia and propionic acidemia
Read More
Bispecific antibody MEDI-7526 stimulates CD40 and downregulates PD-L1
Read More
FDA lifts partial clinical hold on lacutamab TELLOMAK study
Read More
Interim data from phase II study of once-weekly setmelanotide formulation
Read More
Onxeo reports preclinical data for its new generation molecule, OX-401
Read More
IBI-327, a bispecific antibody targeting PD-L1 and OX40 for cancer immunotherapy
Read More
SCOHIA initiates phase II study of SCO-792 in diabetic kidney disease
Read More
First patient dosed in phase II study of TD-0903 for the treatment of ALI caused by COVID-19
Read More
FDA clears first clinical trial of M-5049 in patients with COVID-19 pneumonia
Read More
Merck & Co. divulges new hSTING agonists
Read More
Imperial College of Science, Technology and Medicine discloses MAP4K4 inhibitors
Read More
Novartis presents compounds for arthritis
Read More
Byotrol patent describes antiviral phlorotannins
Read More
Sage Therapeutics synthesizes GABA-A receptor modulators
Read More
Precision model allows accurate cancer therapy testing
Read More
Initiation of phase II study of ABI-H2158 in chronic hepatitis B
Read More
First patient dosed in phase I study of IMT-002
Read More
Discovery of novel orally bioavailable brain-penetrant PRMT5 inhibitor, PRT-811
Read More
BGB-11417 demonstrates promising antitumor activities in hematological tumor models
Read More
FDA approves Fintepla for seizures in Dravet syndrome
Read More
FDA issues complete response letter for abicipar pegol in wet AMD
Read More
Noxopharm to study idronoxil for COVID-19 in phase I trial in Europe
Read More